2015
DOI: 10.1016/j.exger.2015.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Aging without Apolipoprotein D: Molecular and cellular modifications in the hippocampus and cortex

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
36
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(38 citation statements)
references
References 70 publications
1
36
0
1
Order By: Relevance
“…37 A possible role for SMIT in degenerative processes is currently under exploration. The constitutive SMIT levels in the brain 17 were found moderately increased in the hippocampus of aged mice; 38 however, severity of tissue damage was not related to SMIT expression in TgCRND8, a mouse model of Alzheimer's disease-like amyloid pathology. 39 …”
Section: Osmolyte Pathway Activation In Dmmentioning
confidence: 84%
“…37 A possible role for SMIT in degenerative processes is currently under exploration. The constitutive SMIT levels in the brain 17 were found moderately increased in the hippocampus of aged mice; 38 however, severity of tissue damage was not related to SMIT expression in TgCRND8, a mouse model of Alzheimer's disease-like amyloid pathology. 39 …”
Section: Osmolyte Pathway Activation In Dmmentioning
confidence: 84%
“…We have previously analyzed ApoD expression in the nervous system under stress, damage or pathological conditions (Bajo‐Grañeras et al, ; Ganfornina et al, ; Ganfornina et al, ; Garcia‐Mateo et al, ; Li et al, ; Sanchez et al, ), and found that it is up‐regulated in glial cells in both CNS and PNS (reviewed by Dassati, Waldner, & Schweigreiter, ). In the healthy brain, the major cell type expressing ApoD is the mature oligodendrocyte (Supporting Information, Figure S1a and Ganfornina et al, ; Navarro, Del Valle, & Tolivia, ; Ong et al, ; Provost et al, ; Soreq et al, ), and the oligodendrocyte‐specific transcriptome is particularly altered in ApoD‐KO mice (Bajo‐Grañeras et al, ).…”
Section: Resultsmentioning
confidence: 99%
“…Various functional consequences derive from the ApoD‐KO “unfinished” myelin: (1) peripheral nerves decrease their conduction velocity by 40 weeks of age, without alterations in compound action potential amplitude or duration (Ganfornina et al, ) and (2) cerebellum‐dependent motor learning is compromised, without general locomotor deficits or alterations in other cognitive processes in the young adult (e.g., hippocampus‐dependent object recognition tasks, Sanchez et al, ). Cognitive and motor deficits do appear later upon further aging in ApoD‐KO (Ganfornina et al, ; Ganfornina et al, ; Sanchez et al, ), suggesting defective myelin vulnerability to age‐dependent deterioration.…”
Section: Discussionmentioning
confidence: 99%
“…Protein of GPR45 functioned in the central nervous system, and was reported to be related to aging significantly [24]. Moreover, the marker with the greastest weight in tissue-specific models was expression of gene CORO6 in the Kidney renal clear cell model, which has been reported that to be regulated by age [25]. …”
Section: Resultsmentioning
confidence: 99%